ShilpaMHattangadiMD
Pediatric Hematology & Oncology • Bethesda, MDCancer Genetics/Cancer Risk Assessment, Pediatric Anemia and Red Blood Cell Hematology, Pediatric Hematologic Oncology
Hematology Program Director, NIDDK, National Institutes of Health
Dr. Hattangadi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Democracy Plaza Two
6707 Democracy Blvd
Bethesda, MD 20892Phone+1 301-827-7442
Education & Training
Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 2003 - 2006
Johns Hopkins UniversityResidency, Pediatrics, 1999 - 2002
Duke University School of MedicineClass of 1999
Massachusetts Institute of TechnologyBS, Electrican Engineering, Minor in Biology, Tau Beta Pi, 1991 - 1995
Certifications & Licensure
CT State Medical License 2012 - 2021
MA State Medical License 2003 - 2012
NY State Medical License 2002 - 2003- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- 1 citationsAn In Vivo Model for Elucidating the Role of an Erythroid-Specific Isoform of Nuclear Export Protein Exportin 7 (Xpo7) in Murine Erythropoiesis.Susree Modepalli, Sandra Martinez-Morilla, Srividhya Venkatesan, James Fasano, Katerina Paulsen
Experimental Hematology. 2022-10-01 - 6 citationsPleckstrin-2 is essential for erythropoiesis in β-thalassemic mice, reducing apoptosis and enhancing enucleation.Maria Feola, Andrea Zamperone, Daniel Moskop, Huiyong Chen, Carla Casu
Communications Biology. 2021-05-03 - 2 citationsNovel use for selective inhibitors of nuclear export in β-thalassemia: block of HSP70 export from the nucleus via exportin Xpo1 improves ineffective erythropoiesis.Susree Modepalli, Shilpa M. Hattangadi
Haematologica. 2020-06-05
Grant Support
- Transcriptional Regulatory Networks Active In Terminal Erythroid DifferentiationNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2011
Professional Memberships
- Member
External Links
- Yale Pathologyhttp://medicine.yale.edu/pathology/
- Yale Pediatricshttp://medicine.yale.edu/pediatrics/
- Yale Peds Heme-Onchttp://medicine.yale.edu/pediatrics/hematology/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
